Drug therapies in liver disease
Peter Collins, Lachlan Ayres and Talal Valliani
DOI: https://doi.org/10.7861/clinmedicine.13-6-585
Clin Med December 2013 Peter Collins
1University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Roles: consultant hepatologist and clinical chair;
Lachlan Ayres
2Severn Deanery, Bristol, UK
Roles: specialist registrar in hepatology;
Talal Valliani
3North Bristol NHS Trust, Bristol, UK
Roles: consultant hepatologist
Article Information
vol. 13 no. 6 585-591
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online December 2, 2013.
Copyright & Usage:
© 2013 Royal College of Physicians
Author Information
- Peter Collins, consultant hepatologist and clinical chair;1⇑,
- Lachlan Ayres, specialist registrar in hepatology;2 and
- Talal Valliani, consultant hepatologist3
- 1University Hospitals Bristol NHS Foundation Trust, Bristol, UK
- 2Severn Deanery, Bristol, UK
- 3North Bristol NHS Trust, Bristol, UK
- Address for correspondence: Dr P Collins, Department of Hepatology, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW. Email: Peter.Collins{at}UHBristol.nhs.uk
Article usage
Article Tools
Drug therapies in liver disease
Peter Collins, Lachlan Ayres, Talal Valliani
Clinical Medicine Dec 2013, 13 (6) 585-591; DOI: 10.7861/clinmedicine.13-6-585
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.